VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HRHealthcare Realty Trust Incorporated
$20.50$7.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHRCash Flow

Healthcare Realty Trust Incorporated (HR) Cash Flow Statement

30Y historyFree accessUpdated daily

Distributable cash remains constrained by elevated capital expenditures, which consistently exceeded $60 million per quarter, contributing to dividend payout ratios as high as 205% in 2024Q4.

HR Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations462.18M457.1M501.62M499.82M272.75M232.63M470.09M213.14M208.35M179.77M151.27M160.38M125.37M120.8M116.4M105.03M80.83M103.21M106.61M90.92M109.09M101.67M126.24M97.03M109.03M91.34M121.04M91.8M23.5M40.4M29.6M
Operating CF Growth %-1.05%-8.88%0.36%83.25%17.25%-50.51%120.56%2.3%15.9%18.84%-5.68%27.92%3.79%3.78%10.82%29.93%-21.68%-3.19%17.26%-16.65%7.3%-19.47%30.1%-11%19.36%-24.53%31.85%290.64%-41.83%36.49%10.86%
Operating CF / Revenue %40.22%38.72%39.55%37.2%29.24%43.5%63.95%30.73%29.97%29.32%32.85%39.76%33.79%38%38.85%38.27%40.44%79.71%132.57%515.83%-64.04%71.34%64.93%79.78%62.97%79.8%59.84%29.38%77.99%94.57%
Net Income-201.25M-246.07M-663.9M-282.08M40.69M66.66M72.19M39.19M69.77M23.09M85.57M69.44M32.2M6.98M5.54M-184K8.25M51.15M41.69M60.06M39.72M52.67M55.53M70.51M70.09M79.89M79.8M86M40.5M31.2M19.7M
Depreciation & Amortization578.11M567.32M722.32M775.89M477.78M206.51M194.82M180.87M167.2M146.35M131.04M120.36M116.05M105.32M101.44M92.39M77.89M70.92M54.75M53.92M65.53M67.21M60.97M46.16M46.56M45.13M42.83M41.2M17.1M12.1M9M
Stock-Based Compensation24.79M22.39M31.82M14.29M20.35M10.73M9.92M12.28M10.69M10.03M7.6M6.03M4.45M5.21M3.49M2.92M2.41M3.71M2.78M96K00000000000
Other Non-Cash Items50.67M145.75M437.25M62.62M-233.26M-42.74M242.21M-1.46M-2.76M-4.58M-7.13M-3.57M-10.33M-8.18M-73K-4.3M-5.5M-26.08M7.24M12.19M7.97M-5.37M188K-1.54M2.14M-6.81M668K-4.4M2.7M600K400K
Working Capital Changes12.89M-32.29M-25.86M-70.89M-32.81M-8.53M-851K1.35M4.88M-6.13M-24.86M2.56M-19.78M-2.3M1.97M12.56M-1.45M4.18M-1.31M5.15M-4.13M-12.84M9.54M-18.11M-9.77M-26.86M-2.26M-31M-36.8M-3.5M500K
Cash from Investing704.35M710.83M900.92M349.14M1.63B-562.47M-555.17M-418.53M-105.03M-259.45M-237.82M-65.78M-105.59M-207.95M-113.25M-294.67M-350.43M-97.76M-368.88M233.35M-53.55M-35.87M-300.11M-71.82M56.17M19.74M-4.05M-17.9M-89M-67.5M-63.5M
Acquisitions (Net)-694K00-3.82M1.06B-89.6M-65.66M1.23M0-8.7M-4.57M000000-184K882K0126.35M0-355.47M-83.96M-43.74M-53.97M-97.75M0000
Purchase of Investments00000-186.43M-268.36M-581.36M-51.66M-2.48B-591.95M-279.58M000-101.93M-25.11M-23.39M-42.52M0-10.65M0000000000
Sale of Investments00000023.85M5.62M305.84M93.02M27.48M34.63M02.72M000148.92M8.24M311.93M32.71M0000015.05M0000
Other Investing966.07M710.83M1.15B583.99M738.04M-185.75M-151.02M220.65M-34.22M-170.13M-166.39M-17.01M-34.92M-137.88M-90.34M37.37M43.71M-52.59M48.23M52.23M-75.6M51.53M55.36M12.15M99.91M73.71M78.66M-9.1M-89M-67.5M-63.5M
Cash from Financing-1.17B-1.21B-1.36B-884.22M-1.86B327.72M99.72M197.67M-101.16M31.39M136.96M-94.01M-24.93M89.04M-1.1M81.05M377.06M-3.74M257.88M-317.71M-60.63M-61.44M171.64M-21.77M-167.73M-109.94M-118.6M-83.2M74.6M31.1M26.1M
Dividends Paid-362.01M-386.92M-457.85M-472.24M-1.41B-175.46M-275.82M-256.12M-150.27M-142.33M-131.76M-120.27M-116.37M-111.57M-96.36M-89.27M-75.82M-91.39M-81.3M-101.14M-126.2M-125.34M-115.7M-104.29M-105.89M-100.66M-96.23M-92.3M-42.9M-35.8M-25.2M
Common Dividends-278.11M-386.92M-457.85M-472.24M-1.41B-175.46M-162.56M-155.36M-150.27M-142.33M-131.76M-120.27M-116.37M-111.57M-96.36M-89.27M-75.82M-91.39M-81.3M-101.14M-126.2M-125.34M-115.7M-104.29M-105.89M-100.66M-96.23M-92.3M-42.9M-35.8M-25.2M
Debt Issuance (Net)-3M-1000K-1000K-1000K-1000K1000K1000K1000K1000K-1000K-1000K-1000K1000K-1000K-1000K-1000K-1000K1000K1000K-1000K1000K1000K1000K1000K1000K-1000K-1000K1000K1000K-1000K1000K
Share Repurchases-103.79M-4.01M-519.3M-2.3M-3.19M-3.8M-1.44M-5.1M-4.53M-1.69M-1.76M-1.37M-10.07M-454K-68K-86K-51.86M-8K-282K000000000000
Other Financing54.87M-23.17M-6.78M-5.65M-14.45M-405K245.06M-38.86M-6.95M244.55M-4.62M231.46M66.87M216.94M387.73M4.8M378.97M563.42M-156K-227.36M-11.46M0-2.57M15.98M00113K-200K-100K0-200K
Net Change in Cash361K-42.74M43.22M-35.26M47.79M-2.13M14.65M-7.72M2.17M-48.29M50.41M583K-5.15M1.9M2.04M-108.58M107.47M1.71M-4.38M6.57M-5.09M4.35M-2.23M3.44M-2.53M1.14M-1.61M-9.3M74.6M31.1M26.1M
Exchange Rate Effect-152K000000012.8M141.81M-52.24M2.07M-2.52M230K-55.57M148.8M-297.2M88.96M127.25M00000000065.5M27.1M33.9M
Cash at Beginning26.17M68.92M25.7M60.96M13.18M15.3M657K8.38M6.21M54.51M4.1M3.52M8.67M6.78M4.74M113.32M5.85M4.14M8.52M1.95M7.04M2.68M4.92M402K2.93M1.79M3.4M12.7M5.3M1.4M9.1M
Cash at End26.23M26.17M68.92M25.7M60.96M13.18M15.3M657K8.38M6.21M54.51M4.1M3.52M8.67M6.78M4.74M113.32M5.85M4.14M8.52M1.95M7.04M2.68M3.84M402K2.93M1.79M3.4M79.9M32.5M35.2M
Free Cash Flow201.16M126.94M252.64M268.79M109.2M131.94M376.13M148.47M137.55M99.15M79.84M111.61M54.7M48.01M93.49M-125.07M-288.2M-67.31M-277.09M-39.88M-17.26M14.27M126.24M97.03M109.03M91.34M121.04M83M23.5M40.4M29.6M
FCF Growth %-2.13%-49.75%-6.01%146.14%-17.23%-64.92%153.34%7.94%38.72%24.19%-28.46%104.03%13.93%-48.64%174.75%56.6%-328.19%75.71%-594.83%-131.06%-220.98%-88.7%30.1%-11%19.36%-24.53%45.83%253.19%-41.83%36.49%10.86%
FCF / Revenue %17.51%10.75%19.92%20%11.71%24.67%51.17%21.4%19.78%16.17%17.34%27.67%14.74%15.1%31.2%-45.57%-144.19%-51.98%-344.56%-226.25%-8.99%71.34%64.93%79.78%62.97%79.8%54.11%29.38%77.99%94.57%

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Dividend coverage and capital intensity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Dividend Coverage Deficits Observed

As reported in recent financial statements, Healthcare Realty Trust has struggled to maintain dividend coverage, with AFFO failing to cover distributions in multiple quarters, including a 106% payout ratio in 2025Q3 and a 205% ratio in 2024Q4, indicating significant pressure on the company's cash-based distribution capacity.

The recurring inability to cover dividends with AFFO suggests that the current payout level may be unsustainable without reliance on external financing or asset sales. Investors should monitor whether management prioritizes dividend preservation over the capital expenditures required to maintain the competitiveness of their on-campus medical office portfolio.

Capital Intensity Erodes Distributable Cash

Based on the provided cash flow data, property-level capital expenditures remain elevated, consistently exceeding $60 million per quarter, which directly suppresses the REIT's AFFO and limits the cash available for distribution to shareholders after accounting for necessary tenant improvements and building maintenance requirements.

The high level of capital intensity appears to be a structural feature of the portfolio, likely driven by the need to modernize aging on-campus facilities to retain high-value physician tenants. This ongoing requirement for capital reinvestment suggests that the company's true free cash flow is significantly lower than headline FFO figures might imply.

GAAP Net Income Obscures Cash Reality

Financial filings reveal a persistent disconnect between GAAP net income and FFO, with the company reporting negative net income in nine of the last ten quarters, while FFO remained positive in most periods, highlighting the distortive impact of non-cash depreciation and potential impairment charges on reported earnings.

The consistent gap between GAAP losses and positive FFO suggests that investors should focus exclusively on cash-based metrics to evaluate performance. However, the volatility in FFO itself warrants caution, as it may not fully capture the cash-draining effects of the heavy capital expenditure requirements identified in the portfolio.

FFO Conversion Quality Remains Highly Volatile

According to the company's reported figures, the conversion of GAAP operating cash flow into FFO has been erratic, with FFO/NI ratios showing extreme swings, such as the -944.23 ratio in 2026Q1, which underscores the difficulty in reconciling accounting earnings with actual cash-generating capacity post-merger.

This lack of stability in conversion metrics suggests that the company's cash flow profile is currently unpredictable, likely due to integration-related accounting adjustments and fluctuating operational costs. Analysts should remain skeptical of short-term improvements in FFO until the company demonstrates a more consistent relationship between its operating cash flow and core earnings.

HR — Frequently Asked Questions

Quick answers to the most common questions about buying HR stock.

How much cash does Healthcare Realty Trust Incorporated (HR) generate from operations?

Healthcare Realty Trust Incorporated (HR) generated $457.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Healthcare Realty Trust Incorporated's free cash flow?

Healthcare Realty Trust Incorporated (HR) generated $126.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Healthcare Realty Trust Incorporated's capital expenditure (CapEx)?

Healthcare Realty Trust Incorporated (HR) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Healthcare Realty Trust Incorporated distribute cash to shareholders?

In 2025, Healthcare Realty Trust Incorporated (HR) returned $386.9M to shareholders via cash dividends and spent $4.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.